Skip to content
healthcare.dev

Desvenlafaxine

NDC 51991-311, Desvenlafaxine Succinate, tablet, extended release, from Breckenridge Pharmaceutical, Inc.

Product NDC
51991-311
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204003
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE50 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
51991-311-0151991031101100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-01)
51991-311-10519910311101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-10)
51991-311-1151991031111100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-311-11)
51991-311-145199103111414 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-14)
51991-311-335199103113330 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-33)
51991-311-805199103118080 TABLET, EXTENDED RELEASE in 1 CARTON (51991-311-80)
51991-311-905199103119090 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25bdfc41-c7cb-4d16-b6a8-f102f9b8c984
  • NADAC price for package 51991031110

    GET /v1/drugs/nadac/51991031110
  • NADAC price for package 51991031133

    GET /v1/drugs/nadac/51991031133
  • NADAC price for package 51991031190

    GET /v1/drugs/nadac/51991031190

Use it

Look up 51991-311 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.